This study is for people with rheumatoid arthritis (RA), a disease that causes pain and swelling in the joints. The research compares the safety of a medicine called baricitinib with medicines known as tumor necrosis factor (TNF) inhibitors. The study checks for safety issues like venous thromboembolic events (VTEs), which are blood clots in veins.
To join, you need to be at least 50 years old with a certain body weight, or have had a blood clot before. You also must have tried other RA medicines that didn’t work well for you. You cannot join if you have used a similar medicine before, are pregnant, or have had certain health problems like cancer or serious infections.
- Study Length: Details about the study length are not specified.
- Visits: The number of visits required is not mentioned.
- Risks: Possible risks include blood clots and other health issues.
How understandable was the trial content above?
Hard to understand
Easy to understand